Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 5985-00-247-2243
NSN 5895-01-504-0407
NSN 5925-00-499-7407
NSN 5925-00-104-5761
NSN 5935-01-172-2686
NSN 5905-01-009-4419
NSN 5950-01-387-0422
NSN 5996-01-434-9060
NSN 6240-01-105-1399
NSN 5905-00-007-7664
NSN 5998-01-005-1597
NSN 5925-01-116-7032